[Nephropathy and hypertension in type II diabetes].
BACKGROUND
In Germany nephropathy in patients with type II diabetes has become the most frequent single cause of uremia requiring renal replacement therapy. This calls for effective measures of prevention.
In patients with established diabetic nephropathy, hypertension is the most important pathogenetic factor which is susceptible to therapeutic intervention. Some pathogenetic mechanisms are discussed which impact on antihypertensive therapy. Interaction between hypertension and diabetic nephropathy is analyzed.


CONCLUSIONS
Diabetic nephropathy in patients with type II diabetes has become the most frequent cause of endstage renal failure in Germany. Preventive measures, i. e. near normal glycemia and particularly antihypertensive treatment, have been proven to interfere with progression of renal failure in diabetic nephropathy. Early recognition is possible by testing for urinary albumin (microalbuminuria). In patients with diabetic nephropathy, blood pressure should be lowered to values well within the range of normotension by dietary salt restriction and antihypertensive drug therapy.
Ritz
E
E
Medizinische Universitätsklinik Heidelberg.
Bergis
K
K
Strojek
K
K
Keller
C
C
D003131:Combined Modality Therapy; D003922:Diabetes Mellitus, Type 1 / Q000175:diagnosis / Q000628:therapy; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis* / Q000628:therapy; D003928:Diabetic Nephropathies / Q000175:diagnosis* / Q000628:therapy; D006801:Humans; D006973:Hypertension / Q000175:diagnosis* / Q000628:therapy; D007677:Kidney Function Tests; D011379:Prognosis; D012307:Risk Factors; D014511:Uremia / Q000175:diagnosis / Q000628:therapy